These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 10940145)

  • 21. Hormone replacement therapy and the risk of melanoma in post-menopausal women.
    Hicks BM; Kristensen KB; Pedersen SA; Hölmich LR; Pottegård A
    Hum Reprod; 2019 Dec; 34(12):2418-2429. PubMed ID: 31803923
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Side effects and sociobehavioral factors associated with the discontinuation of hormone therapy in a Massachusetts health maintenance organization.
    Reynolds RF; Obermeyer CM; Walker AM; Guilbert D
    Menopause; 2001; 8(3):189-99. PubMed ID: 11355041
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recency and duration of postmenopausal hormone therapy: effects on bone mineral density and fracture risk in the National Osteoporosis Risk Assessment (NORA) study.
    Barrett-Connor E; Wehren LE; Siris ES; Miller P; Chen YT; Abbott TA; Berger ML; Santora AC; Sherwood LM
    Menopause; 2003; 10(5):412-9. PubMed ID: 14501602
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Compliance considerations with hormone replacement therapy.
    Karakoç B; Erenus M
    Menopause; 1998; 5(2):102-6. PubMed ID: 9689204
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hormone replacement therapy: patterns of use studied through British general practice computerized records.
    Lawrence M; Jones L; Lancaster T; Daly E; Banks E
    Fam Pract; 1999 Aug; 16(4):335-42. PubMed ID: 10493702
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Breast cancer in postmenopausal women with and without hormone replacement therapy: preliminary results of the MISSION study.
    Espié M; Mares P; de Reilhac P; Chevallier T; Daurès JP
    Gynecol Endocrinol; 2006 Aug; 22(8):423-31. PubMed ID: 17012103
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hormone replacement therapy among Danish women aged 45-65 years: prevalence, determinants, and compliance.
    Oddens BJ; Boulet MJ
    Obstet Gynecol; 1997 Aug; 90(2):269-77. PubMed ID: 9241307
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Why do women doctors in the UK take hormone replacement therapy?
    Isaacs AJ; Britton AR; McPherson K
    J Epidemiol Community Health; 1997 Aug; 51(4):373-7. PubMed ID: 9328541
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use and discontinuation of hormone replacement therapy in women with myocardial infarction: a nationwide study.
    Bretler DM; Hansen PR; Abildstrøm SZ; Jørgensen CH; Sørensen R; Hansen ML; Schramm TK; Løkkegaard E; Torp-Pedersen C; Gislason GH
    Br J Clin Pharmacol; 2011 Jan; 71(1):105-15. PubMed ID: 21143506
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An evaluation of the benefits of taking hormone replacement therapy with other prescription drugs.
    Jacobs PA; Hyland ME
    Maturitas; 2003 Dec; 46(4):273-81. PubMed ID: 14625124
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Postmenopausal hormone replacement therapy use by older Mexican-American women.
    Newell DA; Markides KS; Ray LA; Freeman JL
    J Am Geriatr Soc; 2001 Aug; 49(8):1046-51. PubMed ID: 11555065
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors predicting current use of hormone replacement therapy among menopausal Jewish women in Israel. The National Women's Health Interview Survey, 1998.
    Merom D; Ifrah A; Cohen-Manheim I; Chinich A; Green MS
    Isr Med Assoc J; 2002 Sep; 4(9):671-6. PubMed ID: 12440227
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hormone replacement and menopausal symptoms following hysterectomy.
    Langenberg P; Kjerulff KH; Stolley PD
    Am J Epidemiol; 1997 Nov; 146(10):870-80. PubMed ID: 9384207
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HRT management: the American experience.
    Carr BR
    Eur J Obstet Gynecol Reprod Biol; 1996 Apr; 64 Suppl():S17-20. PubMed ID: 8732468
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence and causes of persistent use of hormone replacement therapy among postmenopausal women: a follow-up study.
    Ness J; Aronow WS
    Am J Ther; 2006; 13(2):109-12. PubMed ID: 16645425
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trends and determinants of antiresorptive drug use for osteoporosis among elderly women.
    Perreault S; Dragomir A; Desgagné A; Blais L; Rossignol M; Blouin J; Moride Y; Ste-Marie LG; Fernandès JC
    Pharmacoepidemiol Drug Saf; 2005 Oct; 14(10):685-95. PubMed ID: 15645517
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patient-identified needs for hormone replacement therapy counseling: a qualitative study.
    Connelly MT; Ferrari N; Hagen N; Inui TS
    Ann Intern Med; 1999 Aug; 131(4):265-8. PubMed ID: 10454947
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Postmenopausal hormone replacement therapy and venous thromboembolism.
    Wu O
    Gend Med; 2005; 2 Suppl A():S18-27. PubMed ID: 16551553
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The North American Menopause Society 1998 menopause survey: Part II. Counseling about hormone replacement therapy: association with socioeconomic status and access to medical care.
    Ettinger B; Woods NF; Barrett-Connor E; Pressman A
    Menopause; 2000; 7(3):143-8. PubMed ID: 10810958
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes of menopausal hormone therapy use pattern since 2000: results of the Berlin Spandau Longitudinal Health Study.
    Du Y; Scheidt-Nave C; Schaffrath Rosario A; Ellert U; Dören M; Knopf H
    Climacteric; 2009 Aug; 12(4):329-40. PubMed ID: 19437194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.